Frontlight ResearchEarly access
Metastatic breast cancer trials, also abroad
609 open Metastatic breast cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| China | 224 |
| United States | 222 |
| France | 82 |
| Italy | 70 |
| Germany | 52 |
| All other countries |
The same trial often runs in several countries
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) has 7 sites in Spain and runs in 40 countries. If a site near you is full, another one may still take people.
See A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) in all 40 countries